Cerebrovascular events after stentless aortic valve replacement during a 9-year follow-up period

被引:16
作者
Gulbins, Helmut [1 ]
Florath, Ines [1 ]
Ennker, Juergen [1 ]
机构
[1] Univ Witten Herdecke, Inst Cardiovasc Med, Heart Inst Lahr, Dept Cardiac Surg, Hamburg, Germany
关键词
D O I
10.1016/j.athoracsur.2008.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. One major advantage of biologic aortic valve prostheses is their low thrombogenicity compared with mechanical prostheses. The purpose of this study was to evaluate the incidence of cerebrovascular events during long-term follow-up after stentless aortic valve replacement. Methods. Between 1996 and 2005, 1,014 patients (mean age, 73 years; range, 20 to 90 years) received stentless aortic valve replacement (Freestyle; Medtronic, Minneapolis, MN) and were included into the systematic follow-up that was closed in 2006 with a completeness of 94.7% and a mean follow-up interval of 3 years (range, 0.5 to 9.8 years). Predictors for freedom from cerebrovascular events were identified by Cox regression. Results. Overall survival was 53% +/- 5% after 8 years (mean, 6.8 +/- 0.2 years). Permanent atrial fibrillation at time of surgery was a strong predictor of impaired survival during follow-up. Freedom from cerebrovascular events during follow-up was 68% +/- 5% at 9 years of follow-up. Multivariate regression analysis revealed previous stroke, age at implant, diabetes mellitus, and carotid lesions as significant risk factors. Especially age older than 75 years was a strong risk factor for cerebrovascular events during follow-up (p = 0.004). Atrial fibrillation was not an independent risk factor for cerebrovascular events (p = 0.26) but was a strong predictor of poor survival (p < 0.001) during follow-up. There was no influence of technique of implantation (subcoronary versus full root; p = 0.41), sex (p = 0.35), additional bypass grafting (p = 0.65), and the size of the implanted prosthesis (p = 0.47). Conclusions. The risk of cerebrovascular events during follow-up after stentless aortic valve replacement is related to the individual risk factors of the patients rather than to the valve prosthesis itself. Without additional risk factors, patients with these aortic valve prostheses showed an incidence of cerebrovascular events similar to those reported for a healthy population adjusted for age.
引用
收藏
页码:769 / 773
页数:5
相关论文
共 21 条
[1]   Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants - Results from a Danish quality-control registry of 22 179 patients with ischemic stroke [J].
Andersen, Klaus Kaae ;
Olsen, Tom Skyhoj .
STROKE, 2007, 38 (02) :259-263
[2]  
Aupart MR, 2006, J HEART VALVE DIS, V15, P768
[3]   ACC/AHA 2006 guidelines for the management of patients with valvular heart disease [J].
Bonow, Robert O. ;
Carabello, Blase A. ;
Chatterjee, Kanu ;
de Leon, Antonio C., Jr. ;
Faxon, David P. ;
Freed, Michael D. ;
Gaasch, William H. ;
Lytle, Bruce Whitney ;
Nishimura, Rick A. ;
O'Gara, Patrick T. ;
O'Rourke, Robert A. ;
Otto, Catherine M. ;
Shah, Pravin M. ;
Shanewise, Jack S. ;
Smith, Sidney C., Jr. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Anderson, Jeffrey L. ;
Antman, Elliott M. ;
Faxon, David P. ;
Fuster, Valentin ;
Halperin, Jonathan L. ;
Hiratzka, Loren F. ;
Hunt, Sharon A. ;
Lytle, Bruce W. ;
Nishimura, Rick ;
Page, Richard L. ;
Riegel, Barbara .
CIRCULATION, 2006, 114 (05) :E84-E231
[4]   Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years [J].
Carandang, Raphael ;
Seshadri, Sudha ;
Beiser, Alexa ;
Kelly-Hayes, Margaret ;
Kase, Carlos S. ;
Kannel, William B. ;
Wolf, Philip A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2939-2946
[5]  
Dalal P M, 2006, J Assoc Physicians India, V54, P555
[6]  
Deleuze PH, 2006, J HEART VALVE DIS, V15, P247
[7]   Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study [J].
DiMarco, JP ;
Flaker, G ;
Waldo, AL ;
Corley, SD ;
Greene, HL ;
Safford, RE ;
Rosenfeld, LE ;
Mitrani, G ;
Nemeth, M .
AMERICAN HEART JOURNAL, 2005, 149 (04) :650-656
[8]   The stentless freestyle bioprosthesis: Impact of age over 80 years on quality of life, perioperative, and mid-term outcome [J].
Ennker, Juergen ;
Dalladaku, Fatmir ;
Rosendahl, Ulrich ;
Ennker, Ina Carolin ;
Mauser, Manfred ;
Florath, Ines .
JOURNAL OF CARDIAC SURGERY, 2006, 21 (04) :379-385
[9]  
Graf T, 1994, J Heart Valve Dis, V3 Suppl 1, pS49
[10]  
Graf T, 1992, J Heart Valve Dis, V1, P131